H
Henry R. Black
Researcher at Rush University Medical Center
Publications - 207
Citations - 92296
Henry R. Black is an academic researcher from Rush University Medical Center. The author has contributed to research in topics: Blood pressure & Prehypertension. The author has an hindex of 74, co-authored 206 publications receiving 88350 citations. Previous affiliations of Henry R. Black include University of Erlangen-Nuremberg.
Papers
More filters
Journal ArticleDOI
Controlled-release doxazosin as combination therapy in hypertension : The GATES study
TL;DR: Doxazosin gastrointestinal therapeutic system (GITS) or placebo was added to the antihypertensive therapy of uncontrolled hypertensive patients in a prospective, randomized, double‐blind trial.
Journal ArticleDOI
Chrono: a community-based hypertension trial of a chronotherapeutic formulation of verapamil.
TL;DR: This chronotherapeutic formulation of verapamil (Verelan PM) designed to provide maximum plasma concentrations in the midmorning hours was well tolerated in this community trial.
Journal ArticleDOI
Optimal blood pressure: how low should we go?
TL;DR: This study showed that defined blood pressure goals could be safely met and even exceeded and that aggressive antihypertensive treatment allowed more than 90% of patients to achieve goal DBP of < or =90 mm Hg.
Journal ArticleDOI
Calcium Antagonists in Hypertension
TL;DR: There are clear and distinct differences across many of the available agents in this drug class, and dividing these into "dihydropyridine or non-diverse" subclasses has the advantage of being a simple, dichotomous, and clinically-useful scheme.
Journal ArticleDOI
Single-pill combination of telmisartan 80 mg/amlodipine 10 mg provides superior blood pressure reductions in patients with severe hypertension: teamsta severe htn study: ht.1.04
TL;DR: Treatment of severe hypertensive patients with a single-pill combination containing T80/A10 results in significantly greater BP reductions and higher BP control/response rates than the respective monotherapies.